Effect of culture media on expansion properties of human umbilical

cord matrix-derived mesenchymal cells by SALEHINEJAD, PARVIN et al.
 Correspondence:  Seyed Noureddin Nematollahi-Mahani , Kerman Neuroscience Research Center, Avecina St, Tahmasbabad Cross, Kerman, Iran. 
E-mail: nnematollahi@kmu.ac.ir, nematollahimahani@yahoo.com 
 (Received  29  December  2011 ; accepted  03  April  2012 ) 
 Effect of culture media on expansion properties of human umbilical 
cord matrix-derived mesenchymal cells 
 PARVIN  SALEHINEJAD 1,2 ,  NOORJAHAN BANU  ALITHEEN 3 , 
 SEYED NOUREDDIN  NEMATOLLAHI-MAHANI 2,4 ,  ABDUL MANAF  ALI 3 , 
 ABDUL RAHMAN  OMAR 1 ,  EHSAN  JANZAMIN 5  &  MASOOMEH  HAJGHANI 6 
 1 Institute of Bioscience, University Putra Malaysia, Kuala Lumpur, Malaysia,  2 Kerman Neuroscience Research Center, 
Kerman University of Medical Sciences, Kerman, Iran,  3 Faculty of Molecular and Biotechnology, University Putra 
Malaysia, Kuala Lumpur, Malaysia,  4 Department of Anatomy, Afzalipour School of Medicine, Kerman University of 
Medical Sciences, Kerman, Iran,  and 5 Department of Stem Cells, Royan Institute, Tehran, Iran, and  6 Bahonar Hospital, 
Kerman University of Medical Sciences, Kerman, Iran 
 Abstract 
 Background aims. Mesenchymal stromal cells (MSC) have been isolated from a number of different tissues, including 
umbilical cord. Because of the lack of a uniform approach to human umbilical cord matrix-derived mesenchymal (hUCM) 
cell expansion, we attempted to identify the optimum conditions for the production of a high quantity of hUCM cells by 
comparing two media.  Methods. We compared the ability of Dulbecco’s Modifi ed Eagle’s Medium/F12 (DMEM/F12) and 
Alpha Minimum Essential Medium ( α -MEM) with Glutamax (GL) ( α -MEM/GL) to expand hUCM cells. For this pur-
pose, hUCM cells were cultured in plates containing different culture media supplemented with 10% fetal bovine serum 
(FBS). Culture dishes were left undisturbed for 10 – 14 days to allow propagation of the newly formed hUCM cells. The 
expansion properties, CD marker expression, differentiation potential, population doubling time (PDT) and cell activity 
were compared between the two groups.  Results. The hUCM cells harvested from each group were positive for MSC mark-
ers, including CD44, CD90 and CD105, while they were negative for the hematopoietic cell surface marker CD34. Dif-
ferentiation into adipogenic and osteogenic lineages was confi rmed for both treatments. Cell activity was higher in the 
 α -MEM/GL group than the DMEM/F12 group. PDT was calculated to be 60 h for the DMEM/F12 group, while for the 
 α -MEM/GL group it was 47 h.  Conclusions. Our data reveal that  α -MEM/GL with 10% FBS supports hUCM cell growth 
more strongly than DMEM/F12 with 10% FBS. 
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 Introduction 
 For stem cell applications in the treatment of disease, 
the ability to expand the cells  in vitro is an impor-
tant consideration (1,2). Mesenchymal stromal cells 
(MSC) are multipotent cells that were originally 
isolated from bone marrow but have been isolated 
from other adult tissues, including adipose tissue, 
peripheral blood and umbilical cord (UC) (3). 
Despite the need for vast numbers of human MSC 
for therapeutic purposes, sometimes up to 10 9 cells 
(4), often patients with a high need for cell-based 
therapy do not have enough number MSC in their 
bone marrow (5). So it is necessary for MSC to be 
proliferated  in vitro to obtain suffi cient quantities for 
clinical use (3). 
 MSC derived from human UC are highly prolif-
erative and useful human postnatal stem cells (6,7). 
These cells are descendants of the extra-embryonic 
mesoderm at the early stages of development; they 
are highly proliferative, multipotent and pleomor-
phic, yet fi broblast-like, cells located in the mucoid 
connective tissue known as the Wharton ’ s jelly (8). 
Karahuseyinoglu  et  al. (9) divided these cells into 
two types of cells: type I cells, which were more fusi-
form, and type II cells, which were more elongated 
in appearance. In comparison with other sources, 
a relatively large number of human umbilical cord 
matrix-derived mesenchymal (hUCM) cells can be 
harvested, propagated without any feeder cells, and 
stored after birth without any risk to the donor (6). 
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 An option to increase the expansion of Human 
Mesenchymal Cell (hMC) is the addition of supple-
ments to the culture medium (10,11). The compo-
sition of basal medium, glucose concentration and 
stable glutamine concentration can affect the fi nal 
outcome (4). Morphologic differences, and the large 
variety in gene expression, suggest that culture media 
affect the propagation and selection of specifi c cell 
populations (12). The choice of the medium used 
for expansion of MSC is important for enriching the 
culture of desired specifi c cells (13). 
 Several studies have been carried out to compare 
the potential of various media on expansion of differ-
ent cells, but nearly all of them have used bone marrow 
as the source of stem cells. Only a limited number of 
studies has been conducted on areas including hUCM 
cell expansion (8) and no systematic characterization of 
their expansion has been reported. The purpose of this 
study was therefore to identify optimum culture condi-
tions that would result in large numbers of UC mes-
enchymal cells whilst still maintaining potentiality. We 
have evaluated the expansion potential of these cells in 
 α -MEM/Glutamax (GL) medium supplemented with 
10% fetal bovine serum (FBS) compared with a classic 
medium, DMEM/F12, containing 10% FBS. 
 Methods 
 Isolation of hUCM 
 All materials were purchased from Sigma Co. (Sigma-
Aldrich, St Louis, MO, USA) unless stated otherwise. 
Ethical approval was obtained from the institutional 
ethical review board (approval number 69–1780) of 
the Kerman University of Medical Sciences (Kerman, 
Iran). UC were obtained from patients delivering full-
term infants by Caesarian section after written con-
sent had been obtained ( n    5). Fifteen-centimeter 
long cords were immersed in sterile Hanks ’ balanced 
salt solution at 4 ° C, supplemented with penicillin 
(300 U/mL), streptomycin (300  μ g/mL), and ampho-
tericin B (7.5  μ g/mL), and immediately transferred to 
the laboratory. Blood vessels were removed from each 
piece after incising the cord lengthwise, and Whar-
ton ’ s jelly was carefully separated from the amniotic 
membrane. Then the Wharton ’ s jelly was chopped 
into small fragments with sharp scissors and scalpels. 
The fragments were seeded onto the surface of a cul-
ture dish with DMEM/F12 or  α -MEM/GL medium, 
supplemented with 10% FBS, penicillin (100 U/mL), 
streptomycin (100  μ g/mL) and amphotericin B (2.5 
 μ g/mL) for 2 weeks. Within this period, every 5 days, 
half of the medium was refreshed until the fi rst iso-
lated cells appeared and reached approximately 80% 
confl uence. The same procedure was continued until 
the fourth passage in both culture media. 
 Flow cytometry 
 After the fourth passage, the cells were prepared 
at a concentration of 1   10 5 cells/mL in DMEM/
F12 or  α -MEM/GL with 10% FBS. The cells were 
washed with phosphate-buffered saline (PBS), fi xed 
and incubated for 15 min at 4 ° C with a 1:9 dilu-
tion of normal goat serum in PBS, to block non-
specifi c binding of the antibody. The cells were 
labeled with the following antibodies for 1 h: fl uores-
cein isothiocyanate (FITC)-conjugated anti-CD44, 
FITC-conjugated anti-CD34 (Chemicon, Millipore 
Corporation, Billerica, MA, USA), phycoeryth-
rin (PE)-conjugated anti-CD90 (Dako, Glostrup, 
Denmark) and PE-conjugated anti-CD105 (R&D 
Systems, Minneapolis, MN, USA). The cells were 
washed with 2% FBS in PBS and analyzed using a 
FACSCalibur [Becton Dickenson (BD), Pharmin-
gen, San Diego, CA, USA]. The control population 
was stained with matched isotype antibodies (FITC-
conjugated and PE-conjugated mouse IgG mono-
clonal isotype standards), which were confi rmed by 
positive fl uorescence of limbal samples. At least 10 
000 events were recorded for each sample and data 
were analyzed using WinMDI software (West Lafa-
yette, Indiana, USA). 
 Osteogenic and adipogenic differentiation 
 The differentiation of UC MSC was carried out 
in fourth-passage cultures for the two groups. The 
cells were cultured in DMEM/F12 or  α -MEM/GL 
medium, which consisted of either osteogenic (10 
n M dexamethasone, 50  μ g/mL ascorbate-phosphate 
and 10 m M  β -glycerophosphate) or adipogenic (100 
n M dexamethasone, 50  μ g/mL ascorbate-phosphate 
and 50  μ g/mL indomethacin) material. Adipogenic 
differentiation was detected by Oil Red O staining, 
while osteogenic differentiation was detected by Aliz-
arin Red S staining. 
 Detection of cell proliferation 
 In order to detect the activity of the isolated cells, 
a WST-1 assay was used after the fourth passage of 
hUCM cells. WST-1 is an enzyme-linked immuno-
sorbent assay (ELISA)-based one-step method that 
determines mitochondrial respiration (14). One-
hundred-microliter cell suspensions (1   10 4 cells/
mL) were introduced to each well of a 96-well plate 
and incubated at 37 ° C for 48 h. At the end of the 
incubation period, 10  μ L WST-1 solution were added 
to each well. After 1 h incubation at 37 ° C, the absor-
bance of the samples was measured at 450 nm wave-
length and a reference wavelength of 630 nm with an 
ELISA reader (Bio Tek Winooski, Vermont, USA). 
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 Determination of cell proliferation growth curve 
 To obtain the cell proliferation growth curve, aliquots 
of 4   10 4 cells/mL hUCM cells were plated into 21 
35-mm Petri dishes. On days 1 – 7 of culture, three 
dishes were trypsinized and the cells were counted. 
The total number of live cells was obtained at each 
time-point by staining with 0.4% trypan blue and an 
improved Neubauer hemacytometer. The mean dou-
bling time of the hUCM cells was calculated using 
the cell counts from days 1 – 7, and the procedure was 
repeated with cells from three separate cords. The 
mean of the counts was calculated by the following 
formulae: CD   ln( N f / N i )/ln 2 , and DT   CT/CD, 
where DT is the cell-doubling time, CD is the cell-
doubling number and CT is the cell culture time. 
The proliferative rate was calculated from each Petri 
dish, where  N f was the fi nal number of cells and  N i 
was the initial number of cells. 
 Statistical analysis 
 Data from the different tests were expressed as 
mean   SE and analyzed by Student ’ s  t -test. A two- 
way  ANOVA was employed for statistical analysis of the 
population doubling time (PDT) results. A value of 
 P    0.05 was considered signifi cant. 
 Results 
 Morphology of the cells 
 The primary isolated cells formed a monolayer of 
homogenous cells. Most of the cells showed a spin-
dle-like and broad shape, although some of them 
showed a small round shape, in the both groups 
(Figure 1a,b). 
 Flow cytometry 
 The isolated cells in each group were negative for 
the hematopoietic cell-surface marker CD34, while 
the MSC markers CD44, CD90 and CD105 were 
expressed in both groups (Figure 2). The cells in the 
 α -MEM/GL group highly expressed CD44 and CD90 
(87.06    3.79 and 83.02    10.39 respectively), but 
expression of CD105 was slightly higher in the 
DMEM/F12 group (76.39    3.24; Table I). These 
differences were not signifi cant statistically ( P    0.05). 
 Osteogenic and adipogenic differentiation 
 By the end of the third week, adipogenic induction 
resulted in numerous Oil Red-positive cells in both 
groups (Figure 3a,b). Similarly, osteogenic-induced 
 Figure 1. Morphologic features of the isolated cells derived from 
hUCM cells (a). Some of the cells formed a colony (b). Original 
magnifi cation: a   400; b   100. 
 Figure 2. Representative fl ow cytometry results in  α -MEM/GL and 
DMEM/F12 groups. The red histograms are the isotype control-
stained cells; the black histograms are the antibody-stained cells. 
 Table I. Flow cytometry results for the  α -MEM/GL and 
DMEM/F12 groups. Values are the mean   SD percentage of 
cells expressing each surface antigen and were derived from 
three independent experiments. 
Surface 
antigens
DMEM/F12 
group
 a -MEM/GL 
group
CD 34 5.94    0.89 7.64    0.18
CD 44 68.64    5.13 87.06    3.79
CD 90 61.58    9.25 83.02    10.39
CD 105 76.39    3.24 64.10    3.69
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where cell expansion is applicable. But until now, 
even after much research into matching particular 
media to specifi c cell types and culture conditions, 
the choice of medium is not obvious when a specifi c 
cell type is being considered, and is often empirical 
(16). So, in this study, the ability of DMEM/F12 
and  α -MEM/GL to expand hUCM cells was com-
pared. Some properties of the expanded cells, includ-
ing CD marker expression, differentiation potential, 
PDT and cell activity, were different between the two 
groups. Both culture media supported differentia-
tion of hUCM cells into adipogenic and osteogenic 
lineages. Mesenchymal CD markers were expressed 
similarly in both groups. However,  α -MEM/GL 
supported hUCM cell proliferation more effi ciently. 
cells formed Alizarin Red-positive precipitants (Figure 
3c,d). Non-treated control cultures did not show 
spontaneous adipocyte or osteoblast transformation. 
There was no signifi cant difference in osteogenic 
and adipogenic differentiation between the groups 
( P    0.05). 
 Cell proliferation 
 After 48 h culture of hUCM cells, the cell activity 
and proliferation rate were determined with a tetra-
zolium salt assay, which determines cell respiration. 
hUCM cells cultured in  α -MEM/GL proliferated 
signifi cantly more ( P    0.001) than cells cultured in 
DMEM/F12 (Figure 4). 
 Cell proliferation growth curve 
 The increase in cell concentration ( y -axis) during cul-
ture ( x -axis) took almost 6 days for the both groups 
and the cells grew exponentially. The mean total cell 
yield during the expansion period reached 4.3   10 5 
cells in the  α -MEM/GL group and 2.6   10 5 cells in 
the DMEM/F12 group (Figure 5). The mean PDT of 
hUCM cells in the DMEM/F12 group was 60    3 h, 
and in the  α -MEM/GL group it was 47    2.5 h, which 
was signifi cantly shorter ( P    0.001) (Figure 6). 
 Discussion 
 At present, culture expansion is extremely costly and 
time consuming (15). Any improvement in culture 
conditions will facilitate cell therapy procedures 
 Figure 3. Adipogenic differentiation in the  α -MEM/GL (a) and 
DMEM/F12 (b) groups and osteogenic differentiation in the  α -
MEM/GL (c) and DMEM/F12 (d) groups. Results of Alizarin Red 
S are shown by phase – contrast microscopy. Original magnifi cation: 
a, b   400; c, d   100. 
 Figure 4. Evaluation of cell metabolism with WST-1. The activity 
of the expanded cells in the  α -MEM/GL group was signifi cantly 
higher ( * P    0.001) than the DMEM/F12 group. 
 Figure 5. Cell growth curve in the  α -MEM/GL and DMEM/F12 
groups. The red line shows the cell growth process in the  α -MEM/
GL group, and the black line shows the cell growth process in the 
DMEM/F12 group, during 7 days. 
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conditions, exhibit high expandability with a unique 
long-term stability of their phenotype (23). However, 
in our study the expression of MSC markers in both 
groups was almost the same. 
 Furthermore, proliferative activity can affect many 
aspects of cell function. It has been shown that the 
proliferative activity of MSC can be related directly to 
their differentiation potential (10). Our results sup-
port the those of Sotiropoulou et  al. (4), who showed 
that MSC could differentiate into osteocytes and adi-
pocytes in the presence of  α -MEM/GL and DMEM/
F12 media. While minor differences were observed 
in the differentiation potential of  α -MEM/GL and 
DMEM/F12 in vitro (4), a comparison of  α -MEM 
with DMEM has determined that the existence of 
pyruvate in  α -MEM increases cell survival in cul-
tures of osteoblasts in the early proliferative stage of 
growth, but not in later stages of differentiation and 
maturation (25). However, none of the media used 
in this study infl uenced the differentiation potential 
of MSC into adipocytes (26). 
 In an assessment of PDT, the fi rst step is to select 
a suitable cell density. There are contradictory ideas 
about the optimal cell density for PDT. Lund  et  al. 
(19), following an experiment on bone marrow mesen-
chymal cells, found that initial plating densities rang-
ing from 100 to 200 cell/cm 2 resulted in signifi cantly 
shorter doubling times than plating densities both 
below and above that range. Colter  et  al. (27) showed 
human MSC were passed by plating at relatively high 
densities of 5000 cells/cm 2 ; they expanded 3 – 5-fold 
as the cells grew to confl uence over about 2 weeks. 
hUCM cells show higher activity when cultured in 
larger populations (28). Taking our experiments into 
consideration, the cell density chosen was 1000 cell/
cm 2 in both groups. When the cells are plated at low 
density, they typically exhibit three phases of growth: 
a lag phase, a log phase of rapid growth, and then a 
stationary phase (27). But in our study the cells did 
not show any lag phase and their log phase was 6 days. 
After that time, the cells decreased in number without 
any stationary phase. This growth pattern of hUCM 
cells was possibly because of the high cell density, or 
the ability of hUCM cells to accommodate to envi-
ronmental conditions. The log phase of human UC 
stem cells lasts 6 – 8 days (9). During the log phase, 
the cells plated at low density double to an average 
of about twice per 24 h, i.e. the doubling times are 
about 12 h (27). UC-derived MSC have a shorter 
population doubling time (29). The doubling time 
is about 7 days with the Russ protocol, compared 
with 2.5 days with the Gershengorn protocol, and 
the overall expansion rate is 10 5 -fold with the Russ 
protocol, compared with 10 12 -fold with the Gershen-
gorn protocol (30). In our experiment, the expansion 
rate was 4 – 6-fold in the last 6 days in both groups. 
 Many studies have shown  α -MEM medium to 
support cell propagation effectively compared with 
other media (4,17 – 19). In contrast, Nekanti  et  al. 
(20) found that DMEM/F12 was superior com-
pared with the other media tested in supporting  in 
vitro expansion of MSC isolated from Wharton ’ s jelly 
(20). Certainly, DMEM and  α -MEM have differ-
ent characteristics. DMEM is a less nutrient-rich 
medium with amino acids and vitamins, although 
the nutrient concentrations are, on the whole, higher 
than those found in  α -MEM (16). Generally, in 
choosing a medium for a specifi c cell type, glucose 
and glutamine are the most important nutrients for 
the generation of cell energy (ATP), which is neces-
sary for cell growth and maintenance (21).  α -MEM/
GL contains Glutamax, while DMEM/F12 contains 
 L -glutamine. Glutamax compared with  L -glutamine 
has been reported to support MSC growth effi -
ciently. Dipeptide  L -alanyl- L -glutamine, contained 
in media with Glutamax, in contrast to  L -glutamine, 
which is chemically unstable even at 4 ° C, can sup-
port cell propagation and proliferation in some cell 
types. During the activity of living cells in culture 
conditions,  L -glutamine is degraded into ammonium 
ions, which are harmful to living cells (22). 
 In addition, expansion can be associated with 
a loss of phenotype, which would not be uncom-
mon in human cell populations with a high expan-
sion potential (23). The expression of a particular 
cell phenotype in culture depends on the biologic 
material used (and its manipulation), the culture 
medium (16), the different growth conditions used 
in the laboratories, and technical differences in gat-
ing (24). UC stromal cells, under specifi c culture 
 Figure 6. PDT for the  α -MEM/GL and DMEM/F12 groups. 
PDT was calculated to be 60 h for the DMEM/F12 group, while 
it was 47 h for the  α -MEM/GL group. This difference was 
statistically signifi cant ( * P    0.001). 
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